Progesterone receptor expression contributes to gemcitabine resistance at higher ECM stiffness in breast cancer cell lines.
Chemoresistance poses a great barrier to breast cancer treatment and is thought to correlate with increased matrix stiffness. We developed two-dimensional (2D) polyacrylamide (PAA) and three-dimensional (3D) alginate in vitro models of tissue stiffness that mimic the stiffness of normal breast and b...
Saved in:
| Main Authors: | Emma Grant, Fatma A Bucklain, Lucy Ginn, Peter Laity, Barbara Ciani, Helen E Bryant |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0268300&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
YAP and ECM Stiffness: Key Drivers of Adipocyte Differentiation and Lipid Accumulation
by: Da-Long Dong, et al.
Published: (2024-11-01) -
Progesterone and progesterone receptors in breast cancer: past, present, and future
by: M. V. Rodionova, et al.
Published: (2025-03-01) -
Matrix Stiffness Affects Spheroid Invasion, Collagen Remodeling, and Effective Reach of Stress into ECM
by: Klara Beslmüller, et al.
Published: (2025-06-01) -
ECM stiffness regulates calcium influx into mitochondria via tubulin and VDAC1 activity
by: Minji Kim, et al.
Published: (2024-12-01) -
Research progress on estrogen receptor-positive/progesterone receptor-negative breast cancer
by: Zhengjia Lu, et al.
Published: (2025-06-01)